Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
2 Aug 2021
Treating Ankylosing Spondylitis Using Engineered JAK Inhibitor: Upadacitinib
Researchers explored the efficacy of upadacitinib in treating AS. Upadacitinib targets the inflammatory pathway and works by inhibiting JAK, reducing the ability of JAK to cause inflammation in the joints.
2 Aug 2021
Effective Novel Drug for Axial Psoriatic Arthritis
Phase III clinical trials analysed the efficaPhase III clinical trials analysed the efficacy of a novel antibody, guselkumab, for psoriatic arthritis with axial symptoms.
30 Jul 2021
Two Pilots Walk into a Pharmacy
We discuss the role of pharmacists on hospital wards, explore microbial stewardship, consider the evidence behind aspirin as a prevention tool.
28 Jul 2021
Webinar: Acute MSK pain: how to manage symptoms and stress
Musculoskeletal (MSK) pain and soft tissue injuries are very common both in sportspeople and in the general population and include different forms of traumas that must be properly treated to allow the return to normal life or sports activities.
Talking to Jennifer Cain Birkmose
Jennifer Cain Birkmose, Senior Pharmaceutical Leader in Market Access, Patient Access, and Patient Advocacy, discusses clinical trials.
11
Mins
27 Jul 2021
Review of the European Hematology Association (EHA) 2021 Virtual Congress
THE GLOBAL community of clinicians and researchers shared in the latest advances in haematology care online at the 26th European Hematology Association (EHA) 2021 Virtual Congress.
5
Mins
27 Jul 2021
Diagnosis, Treatment, Impact, and Unmet Needs of People with Mycosis Fungoides and Sézary Syndrome
Mycosis fungoides (MF) and Sézary syndrome (SS), two of the most-studied types of cutaneous T-cell lymphoma (CTCL), account for approximately 60% and 10% of CTCL cases, respectively.
1
Mins
27 Jul 2021
COVID-19 in Patients with Acute Leukaemia: The Experience of a Haematological Centre
Patients with haematologic malignancies appear to have a greater risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe disease due to myelosuppression.
3
Mins
27 Jul 2021
EULAR Interview: Ruud Delwel
EMJ sits down with Ruud Delwel, Chair of the Scientific Program Committee, European Hematology Association (EHA) 2021 Virtual Congress.
8
Mins
27 Jul 2021
Interview: Nikhil Munshi
We are talking about 35 years ago, and some of what drew me to the practice is still true today. There were two major aspects of cancer…
←
1
2
3
…
564
565
566
567
568
569
570
…
1,065
1,066
1,067
→